Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription

ISSN: 1874-4702 (Online)
ISSN: 1874-4672 (Print)

Volume 9, 4 Issues, 2016

Download PDF Flyer

Current Molecular Pharmacology

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Michael Kahn
University of Southern California
1450 Biggy Street
Los Angeles, NRT 4501, CA 90033

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Hypoxia Selects for a Quiescent, CML Stem/Leukemia Initiating- Like Population Dependent on CBP/Catenin Transcription

Current Molecular Pharmacology, 6(3): 204-210.

Author(s): Aiko Kida and Michael Kahn.

Affiliation: University of Southern California, 1450 Biggy Street, NRT 4501, Los Angeles, CA 90033, USA.


Hypoxia has been reported to regulate both stem cell maintenance and differentiation. Wnt signaling is also a key regulator in stem cells. The recent discovery of functional cross-regulation between the Wnt pathway and HIF- 1α/HIF-2α signaling further highlights the complexity of the role of hypoxia in the regulation of stem cells. In this report we reveal that human CML cell lines treated under hypoxic conditions increase the percentage of leukemia stem/initiating-like cells, as judged by surface marker expression, colony forming ability and quiescence. We demonstrate that differential usage of the Kat3 coactivators, CREBBP/Creb Binding Protein (CBP) and EP300 (p300) by catenin, with increased CBP/catenin signaling at the expense of p300/catenin signaling, is mechanistically correlated with the increase in the leukemia stem/initiating-like population. A specific small molecule inhibitor of CBP/catenin dependent transcription, ICG-001, can reverse these effects further demonstrating the critical involvement of CBP/catenin signaling in enhancing and maintaining the leukemia stem/initiating-like cell population under hypoxic conditions.


CBP, CML, ICG-001, hypoxia, leukemia initiating cell, Wnt/catenin inhibitor.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 6
Issue Number: 3
First Page: 204
Last Page: 210
Page Count: 7
DOI: 10.2174/1874467207666140219121219
Global Biotechnology Congress 2016Drug Discovery and Therapy World Congress 2016

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science